For instance, in glioma xenograft-bearing mice, combining PD-1 blockade and dose brain-directed radiation (10 Gy) glioma xenograft-bearing mice resulted in a 75% complete pathologic response, as well as improving OS largely due to activation of CTLs and macrophages [96]. The gene discussed is PDCD1; the disease is central nervous system cancer.